Compared with the CKD group, the serum levels of FGF23, phosphorus, and PTH in the CKD+Spir and CKD+AIF-1KO groups were greatly relieved (P<0.05) (Figure 2). This evidence concerns the gene FGF23 and chronic kidney disease.